Survival [acty]
Old [tmco]
Persons [popg]
Objective [inpr]
Old [tmco]
Persons [popg]
Hypertension [dsyn]
Specific [qlco]
calcium antagonist [phsu]
ACE Inhibitors [phsu]
Mortality [qnco]
Beta-Blockers [phsu]
Design [acty]
Prospective Cohort Study [resa]
Continuing [idcn]
setting [ftcn]
Communities [geoa]
Established [qlco]
Epidemiologic Studies [resa]
Elderly [popg]
participants [popg]
hypertensive [fndg]
participants [popg]
Aged [orga]
Equal [qlco]
N NOS [aapp, imft]
Congestive heart failure [dsyn]
Beta-Blockers [phsu]
N NOS [aapp, imft]
Verapamil [orch, phsu]
N NOS [aapp, imft]
Diltiazem [orch, phsu]
N NOS [aapp, imft]
Nifedipine [orch, phsu]
N NOS [aapp, imft]
ACE Inhibitors [phsu]
N NOS [aapp, imft]
Nifedipine [orch, phsu]
short [qlco]
Variety [cnce]
measurements [ftcn]
Main [qlco]
outcome measure [qnco]
Mortality [qnco]
Age [orga]
Gender [orga]
Smoking [inbe]
Cholesterol, HDL [bacs, lipd]
Blood Pressure [orgf]
Intake [ftcn]
Digoxin [carb, phsu, strd]
Diuretics [phsu]
Physical disability [patf]
Self [idcn]
Perceived [menp]
Health [idcn]
Co-morbid conditions [fndg]
Examined [fndg]
Person [popg]
participants [popg]
Died [orgf]
deaths [orgf]
Person [popg]
Compared [acty]
Beta-Blockers [phsu]
Age [orga]
Gender [orga]
Co-morbid conditions [fndg]
Health [idcn]
Risks, Relative [qnco]
Mortality [qnco]
Verapamil [orch, phsu]
Diltiazem [orch, phsu]
Nifedipine [orch, phsu]
ACE Inhibitors [phsu]
1-7 [gngm]
1-7 [gngm]
Unchanged [fndg]
Exclude [ftcn]
participants [popg]
contraindications [qlco]
Beta-Blockers [phsu]
stratifying [qlco]
coronary heart disease [dsyn]
Diuretics [phsu]
High dose [qnco]
Nifedipine [orch, phsu]
Mortality [qnco]
Compared [acty]
Beta-Blockers [phsu]
short [qlco]
Nifedipine [orch, phsu]
Decreased [qnco]
Survival [acty]
Old [tmco]
hypertensive [fndg]
Persons [popg]
Specific [qlco]
Drugs [phsu]
High Risk [qlco]
Patients [podg]
Completely [qlco]
discount [inpr]
Final [tmco]
Conclusions [idcn]
depend [medd]
Clinical Trials [resa]
